| 11th Mar 2015 4:08 pm |
RNS |
Holding(s) in Company |
| 11th Mar 2015 12:41 pm |
RNS |
Holding(s) in Company |
| 10th Mar 2015 7:03 am |
RNS |
Notice of Full Year Results |
| 6th Mar 2015 2:22 pm |
RNS |
Holding(s) in Company |
| 26th Feb 2015 1:55 pm |
RNS |
Stmnt re Share Price Movement |
| 21st Jan 2015 11:20 am |
RNS |
Director/PDMR Shareholding |
| 7th Jan 2015 7:00 am |
RNS |
Awards made under Performance Share Plan |
| 7th Jan 2015 7:00 am |
RNS |
Issue of Equity |
| 5th Jan 2015 7:00 am |
RNS |
Directorate Change |
| 19th Dec 2014 7:00 am |
RNS |
e-Therapeutics' Impact is rated World Class |
| 18th Dec 2014 7:00 am |
RNS |
Update: ETS2101 Phase 1a and Oral Dosing Studies |
| 27th Nov 2014 7:00 am |
RNS |
Research and Development presentation to Investors |
| 16th Oct 2014 8:35 am |
RNS |
Appointment of Executive Director |
| 16th Sep 2014 7:00 am |
RNS |
Half Yearly Report |
| 4th Sep 2014 2:55 pm |
RNS |
Notice of Results |
| 5th Aug 2014 7:00 am |
RNS |
Additional Listing |
| 1st Aug 2014 9:22 am |
RNS |
Issue of equity and Directors' shareholdings |
| 9th Jul 2014 11:31 am |
RNS |
AGM Statement |
| 9th Jul 2014 7:00 am |
RNS |
Awards made under Performance Share Plan |
| 4th Jul 2014 7:00 am |
RNS |
Director/PDMR Shareholding |
| 27th Jun 2014 7:00 am |
RNS |
Change of Adviser |
| 25th Jun 2014 4:11 pm |
RNS |
Director/PDMR Shareholding |
| 25th Jun 2014 3:57 pm |
RNS |
Holding(s) in Company |
| 20th Jun 2014 4:22 pm |
RNS |
Holding(s) in Company |
| 20th Jun 2014 1:41 pm |
RNS |
Holding(s) in Company |
| 18th Jun 2014 6:14 pm |
RNS |
Additional Listing |
| 30th May 2014 7:00 am |
RNS |
Annual Financial Report and Notice of AGM |
| 22nd May 2014 4:15 pm |
RNS |
Issue of Equity |
| 12th May 2014 7:00 am |
RNS |
Full year results |
| 8th May 2014 7:00 am |
BUS |
e-Therapeutics announces recruitment resumes into US phase I ETS2101 brain cancer trial |
| 2nd May 2014 4:46 pm |
RNS |
Holding(s) in Company |
| 2nd May 2014 4:42 pm |
RNS |
Holding(s) in Company |
| 2nd May 2014 4:29 pm |
RNS |
Holding(s) in Company |
| 25th Apr 2014 7:00 am |
RNS |
Notice of Results |
| 7th Apr 2014 1:07 pm |
RNS |
Directorate Change |
| 7th Apr 2014 11:46 am |
RNS |
Directorate Change |
| 31st Mar 2014 6:56 am |
BUS |
e-Therapeutics reports positive interim results from UK phase Ia trial of ETS2101 (dexanabinol) in a variety of solid tumours |
| 26th Mar 2014 7:00 am |
BUS |
e-Therapeutics announces recruitment resumes into UK phase I ETS2101 cancer trial |
| 10th Feb 2014 7:02 am |
BUS |
e-Therapeutics Begins Phase I Study of Oral Formulation of Anti-Cancer Compound ETS2101 with Healthy Volunteers |
| 24th Jan 2014 7:00 am |
BUS |
Temporary halt of recruitment into ETS2101 cancer trials because of drug supply issue - Patients already being treated will continue to be dosed |
